Endometriosis Trial, Recruiting NCT05339451 Sponsor: Region Stockholm Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT05339451
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women of childbearing age (18–45) who are having surgery because doctors suspect they may have endometriosis (for example, due to painful periods, pain during sex, or difficulty getting pregnant)
  • Women of childbearing age (18–45) who are having keyhole surgery for other non-cancerous gynaecological reasons (such as ovarian cysts, sterilisation, or fibroids) and where no signs of endometriosis are found during the operation
  • Women who can speak and understand Swedish or English well enough to fill in questionnaires and give their agreement to take part in the study

Who may not be able to join:

  • Women with a Body Mass Index (BMI) over 40
  • Women who have gone through menopause
  • Women whose ovaries have stopped working earlier than expected (known as premature ovarian failure)
  • Women who have or have had an infection or inflammation in the pelvic area (pelvic inflammatory disease)
  • Women who currently have or have previously had any form of cancer
  • Women who are pregnant or have given birth within the last 6 months
  • Women who have taken steroid medications (corticosteroids) within the last 3 months
  • Women with known diseases affecting the pituitary gland, kidneys, liver, or adrenal glands
  • Women with abnormal thickening of the womb lining (endometrial hyperplasia) or growths inside the womb (endometrial polyps)
  • Women with heart conditions or other widespread inflammatory conditions affecting the body

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kenny Rodriguez-Wallberg, Professor, Karolinska Institutet

Phone: 0046 735500118

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Region Stockholm
Registry
ClinicalTrials.gov
Start date
4 May 2023
Est. completion
31 December 2025

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Measurement of blood biomarkers panel for the diagnosis of endometriosis with sensitivity 94%; Change in blood biomarkers levels 3-6 months postoperative in patients with severe endometriosis.; Measurement of blood biomarkers panel for the diagnosis of endometriosis with specificity 79%

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov